Page last updated: 2024-08-17

estrone and medroxyprogesterone acetate

estrone has been researched along with medroxyprogesterone acetate in 61 studies

Research

Studies (61)

TimeframeStudies, this research(%)All Research%
pre-199011 (18.03)18.7374
1990's29 (47.54)18.2507
2000's16 (26.23)29.6817
2010's5 (8.20)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ban, F; Cherkasov, A; Fallahi, M; Hammond, GL; Santos-Filho, O; Thorsteinson, N1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Jensen, HK; Pedersen, OD1
Caplan, RH; Hodgson, SF; Judd, HL; Kotowicz, MA; Lane, AW; Lufkin, EG; O'Fallon, WM; Riggs, BL; Wahner, HW1
Bellantoni, MF; Blackman, MR; Cho, DE; Harman, SM1
Bellantoni, MF; Blackman, MR; Cullins, VE; Engelhardt, SM; Harman, SM1
Sherwin, BB1
Cedars, MI; Judd, HL; Lu, JK; Meldrum, DR1
Dikkeschei, LD; Sleijfer, DT; Tjabbes, T; van Veelen, H; Willemse, PH1
Lundgren, S; Lønning, PE1
Coldham, NG; Ghilchik, MW; James, VH; Lai, LC; Purohit, A; Reed, MJ; Singh, A1
Dowsett, M; Jeffcoate, SL; Lal, A; Smith, IE1
Lobo, RA; Montz, FJ; Shoupe, D1
Alapin-Rubillovitz, S; Casper, RF1
Adlercreutz, H; Hämäläinen, EK; Korpela, JT; Pulkkinen, MO1
Carlström, K; Döberl, A; Pousette, A; Rannevik, G; Wilking, N1
Lobo, RA; McCormick, W; Roy, S; Singer, F1
Evans, CA; Kennedy, TG1
Liu, HC; Tseng, L1
Bassol, S; Hernandez, C; Luz de la Cruz, D; Nava, MP; Trujillo, AM1
Aono, T; Hata, K; Irahara, M; Sunahara, S; Uemura, H; Yasui, T; Yoneda, N1
Geng, CS; Labrie, F; Lévesque, C; Li, S; Yan, X1
Nand, SL; Webster, MA; Wren, BG1
Leung, B; Lobo, R; Mezrow, G; Pike, M; Shoupe, D; Spicer, D1
Johnson, SH; Olsson, SE; Svensson, LO1
Castiglioni, E; Farina, M; Gabrielli, L; Nencioni, T; Penotti, M; Polvani, F1
Couture, P; Labrie, F; Simard, J; Thériault, C1
Dowsett, M; Edmonds, DK; Howell, R; King, N1
Collins, WP; Jaggers, DC; Milligan, SR1
Barbieri, RL; Gao, X; Ginsburg, ES; Mello, NK; Mendelson, JH; Rothman, M; Sholar, JW; Teoh, SK1
AinMelk, Y1
Affandi, B; Belsey, EM; d'Arcangues, C; Dusitsin, N; Hadisaputra, W; Kazi, A; Kirwat, O; Koetsawang, S; Noonan, E; Olayinka, I; Pinol, A; Piya-Anant, M; Ramos, RM; Rocca, M; Sadek, W; Said, S; Sethavanich, S1
Doyle, MC; Feely, J; Harrison, RF; Wen, Y1
Labrie, C; Labrie, F; Luo, S; Stojanovic, M1
Hall, G; Landgren, BM; Pripp, U; Schenck-Gustafsson, K1
Baber, R; Nand, SL; O'Connor, V; Webster, MA1
Adams, MR; Schwenke, DC; Wagner, JD1
Gross, BA; Heller, GZ; Nand, SL; Wren, BG1
Arcuri, F; Carducci, A; Cintorino, M; Paulesu, L; Ricci, C; Runci, Y; Sestini, S1
Honjo, H; Iwasa, K; Kikuchi, N; Okubo, T; Tsuchiya, H; Urabe, M; Yamamoto, T; Yokota, K1
Luciano, AA; Miller, BE; Schaser, RJ; Schoenenfeld, MJ1
Fukaya, T; Ikenoue, N; Okatani, Y; Wakatsuki, A1
Aono, T; Irahara, M; Kamada, M; Kinoshita, H; Kiyokawa, M; Tezuka, M; Uemura, H; Yamada, M; Yasui, T1
Benencia, H; Gutierrez, P; Mesch, V; Novelli, JA; Siseles, NO1
Baber, R; Heller, GZ; Nand, SL; Webster, MA1
Hyde, BM; Wilborn, WH1
Fukaya, T; Okatani, Y; Wakatsuki, A1
Alvarez-Vasquez, RB; Axelrod, D; Bradlow, HL; Frenkel, K; Newman, MC; Sepkovic, DW; Zumoff, B1
Edwards, JP; Jones, TK; Mais, DE; Marschke, KB; Motamedi, M; Pio, B; Risek, B; Schrader, WT; Tegley, CM; Zhi, L1
BARNES, LE; MEYER, RK1
Bhagat, CI; Criddle, RA; Dhaliwal, SS; Drury, PJ; Faulkner, DL; Gutteridge, DH; Holzherr, ML; Jamrozik, K; Kent, GN; Price, RI; Prince, RL; Retallack, RW; Stewart, GO; Stuckey, BG; Tran, L; Will, RK1
Furumoto, H; Irahara, M; Kuwahara, A; Maegawa, M; Matsuzaki, T; Miura, M; Saito, S; Takikawa, M; Uemura, H; Umino, Y; Yasui, T2
Greendale, GA; Palla, SL; Pike, MC; Reboussin, BA; Slone, S; Ursin, G; Wasilauskas, C1
Barrett-Connor, E; Crandall, C; Greendale, GA; Herrington, DM; Hu, P; Palla, SL; Reboussin, BA; Reuben, DB1
Greenberg, DL; Krishnan, RR; MacFall, JR; Payne, ME; Provenzale, JM; Steffens, DC1
Blok, LJ; Burger, CW; Hanifi-Moghaddam, P; Kloosterboer, HJ; Verheul, HA1
Kaplan, PF; Meendering, JR; Minson, CT; Torgrimson, BN1

Trials

28 trial(s) available for estrone and medroxyprogesterone acetate

ArticleYear
Treatment of postmenopausal osteoporosis with transdermal estrogen.
    Annals of internal medicine, 1992, Jul-01, Volume: 117, Issue:1

    Topics: Administration, Cutaneous; Administration, Oral; Aged; Bone Density; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Spinal Fractures

1992
Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages.
    The Journal of clinical endocrinology and metabolism, 1991, Volume: 72, Issue:1

    Topics: Aged; Aging; Body Mass Index; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Growth Hormone; Humans; Insulin-Like Growth Factor I; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged

1991
Transdermal estradiol with oral progestin: biological and clinical effects in younger and older postmenopausal women.
    Journal of gerontology, 1991, Volume: 46, Issue:6

    Topics: Administration, Cutaneous; Administration, Oral; Aged; Aging; Analysis of Variance; Body Mass Index; Body Weight; Delayed-Action Preparations; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Menstruation; Middle Aged; Placebos; Vagina

1991
The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women.
    The Journal of clinical endocrinology and metabolism, 1991, Volume: 72, Issue:2

    Topics: Affect; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Sexual Behavior; Testosterone

1991
Adrenal steroids as parameters of the bioavailability of MA and MPA.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:3

    Topics: Adrenal Cortex Hormones; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrone; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate

1990
Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer--II. A differential effect of megestrol acetate and medroxyprogesterone acetate on serum estrone sulfate and sex hormone binding globulin.
    Journal of steroid biochemistry, 1990, Volume: 36, Issue:1-2

    Topics: Aged; Aged, 80 and over; Breast Neoplasms; Estradiol; Estrone; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Sex Hormone-Binding Globulin

1990
Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
    Journal of steroid biochemistry, 1984, Volume: 20, Issue:1

    Topics: Adult; Contraceptive Agents, Female; Erythromycin; Estradiol; Estrone; Ethinyl Estradiol; Feces; Female; Humans; Intestines; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Norethindrone; Oxytetracycline; Trimethoprim

1984
A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives.
    Contraception, 1995, Volume: 51, Issue:5

    Topics: Adult; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Estrone; Female; Glucuronates; Humans; Injections, Intramuscular; Kinetics; Medroxyprogesterone Acetate; Mexico; Norethindrone; Ovulation; Pregnanediol

1995
Continuous combined piperazine oestrone sulphate and medroxyprogesterone acetate hormone replacement therapy--a study of bleeding pattern, endometrial response, serum lipid and bone density changes.
    The Australian & New Zealand journal of obstetrics & gynaecology, 1995, Volume: 35, Issue:1

    Topics: Administration, Oral; Bone Density; Drug Therapy, Combination; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Humans; Lipids; Medroxyprogesterone Acetate; Middle Aged; Pilot Projects; Uterine Hemorrhage

1995
Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome.
    Fertility and sterility, 1994, Volume: 62, Issue:5

    Topics: Adult; Bone Density; Delayed-Action Preparations; Endometrium; Estradiol; Estrogens; Estrone; Female; Humans; Leuprolide; Medroxyprogesterone Acetate; Premenstrual Syndrome; Prospective Studies

1994
Plasma concentrations of medroxyprogesterone acetate, estradiol and estrone following oral administration of Klimaxil, Trisequence/Provera and Divina. A randomized, single-blind, triple cross-over bioavailability study in menopausal women.
    Maturitas, 1994, Volume: 18, Issue:3

    Topics: Administration, Oral; Biological Availability; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Reference Values; Single-Blind Method

1994
Endocrine effects of GnRH analogue with low-dose hormone replacement therapy in women with endometriosis.
    Clinical endocrinology, 1995, Volume: 43, Issue:5

    Topics: Adult; Antineoplastic Agents, Hormonal; Endometriosis; Estradiol; Estrogen Replacement Therapy; Estrone; Feedback; Female; Follicle Stimulating Hormone; Goserelin; Humans; Inhibins; Luteinizing Hormone; Medroxyprogesterone Acetate; Prospective Studies

1995
Effects of alcohol ingestion on estrogens in postmenopausal women.
    JAMA, 1996, Dec-04, Volume: 276, Issue:21

    Topics: Alcohol Drinking; Cross-Over Studies; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Estrone; Ethanol; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause

1996
Comparison of two continuous combined estrogen progestogen regimens in postmenopausal women: a randomized trial.
    Fertility and sterility, 1996, Volume: 66, Issue:6

    Topics: Blood Pressure; Drug Combinations; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Humans; Lipids; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Prospective Studies; Ultrasonography; Uterine Hemorrhage

1996
Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Developmen
    Human reproduction (Oxford, England), 1996, Volume: 11 Suppl 2

    Topics: Adolescent; Adult; Contraceptive Agents, Female; Double-Blind Method; Estradiol Congeners; Estrogens, Conjugated (USP); Estrone; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone Acetate; Menstruation; Time Factors; Treatment Outcome; Uterine Hemorrhage

1996
Long-term effects of hormone replacement therapy on symptoms of angina pectoris, quality of life and compliance in women with coronary artery disease.
    Maturitas, 1998, Jan-12, Volume: 28, Issue:3

    Topics: Aged; Angina Pectoris; Cohort Studies; Coronary Disease; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hormone; Humans; Medroxyprogesterone Acetate; Middle Aged; Patient Compliance; Postmenopause; Progesterone Congeners; Quality of Life; Safety; Time Factors

1998
Bleeding pattern and endometrial changes during continuous combined hormone replacement therapy. The Ogen/Provera Study Group.
    Obstetrics and gynecology, 1998, Volume: 91, Issue:5 Pt 1

    Topics: Adult; Biopsy, Needle; Double-Blind Method; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Uterine Hemorrhage

1998
Bone density effects of continuous estrone sulfate and varying doses of medroxyprogesterone acetate. Ogen/Provera Study Group.
    Obstetrics and gynecology, 1999, Volume: 93, Issue:6

    Topics: Adult; Bone Density; Double-Blind Method; Estrogens, Conjugated (USP); Estrone; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Progesterone Congeners

1999
Effects of estrone sulfate alone or with medroxyprogesterone acetate on serum lipoprotein levels in postmenopausal women.
    Obstetrics and gynecology, 2001, Volume: 97, Issue:1

    Topics: Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Drug Combinations; Estrone; Female; Humans; Lipoproteins; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Triglycerides

2001
Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen.
    Circulation, 2001, Oct-09, Volume: 104, Issue:15

    Topics: Blood Flow Velocity; Blood Pressure; Brachial Artery; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Drug Antagonism; Endothelium, Vascular; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Heart Rate; Humans; Japan; Lipoproteins, LDL; Medroxyprogesterone Acetate; Middle Aged; Oxidation-Reduction; Postmenopause; Ultrasonography; Vascular Patency; Vasodilation; Vasodilator Agents

2001
Efficacy of every-other-day administration of conjugated equine estrogen and medroxyprogesterone acetate on gonadotropin-releasing hormone agonists treatment in women with endometriosis.
    Gynecologic and obstetric investigation, 2001, Volume: 52, Issue:4

    Topics: Adult; Animals; Bone Density; Bone Remodeling; CA-125 Antigen; Endometriosis; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Gonadotropin-Releasing Hormone; Horses; Humans; Leuprolide; Medroxyprogesterone Acetate; Middle Aged; Uterine Hemorrhage

2001
Once and twice a week transdermal estradiol delivery systems: clinical efficacy and plasma estrogen levels.
    Climacteric : the journal of the International Menopause Society, 1998, Volume: 1, Issue:3

    Topics: Administration, Cutaneous; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Protein Binding; Sex Hormone-Binding Globulin

1998
Menopausal symptom control and side-effects on continuous estrone sulfate and three doses of medroxyprogesterone acetate. Ogen/Provera Study Group.
    Climacteric : the journal of the International Menopause Society, 1998, Volume: 1, Issue:3

    Topics: Adult; Affect; Breast; Depression; Double-Blind Method; Estrogen Replacement Therapy; Estrone; Female; Headache; Humans; Libido; Medroxyprogesterone Acetate; Menopause; Middle Aged; Nausea; Pain; Vaginal Diseases; Vasomotor System

1998
A randomized trial comparing hormone replacement therapy (HRT) and HRT plus calcitriol in the treatment of postmenopausal osteoporosis with vertebral fractures: benefit of the combination on total body and hip density.
    Calcified tissue international, 2003, Volume: 73, Issue:1

    Topics: Absorptiometry, Photon; Aged; Biomarkers; Bone Density; Calcitriol; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Hip Joint; Humans; Hydroxyproline; Medroxyprogesterone Acetate; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Quality of Life; Severity of Illness Index; Single-Blind Method; Spinal Fractures; Treatment Outcome

2003
Serum estradiol concentration as measured by HPLC-RIA and bone mineral density in postmenopausal women during hormone replacement therapy.
    Hormone research, 2004, Volume: 61, Issue:3

    Topics: Adult; Aged; Bone Density; Chromatography, High Pressure Liquid; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Radioimmunoassay; Spine

2004
Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Jul-15, Volume: 22, Issue:14

    Topics: Breast; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Predictive Value of Tests; Progesterone; Progesterone Congeners; Randomized Controlled Trials as Topic

2004
Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
    Maturitas, 2005, Jan-10, Volume: 50, Issue:1

    Topics: Administration, Oral; Body Mass Index; Contraceptive Agents, Female; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Ovariectomy; Postmenopause

2005
Levels of tibolone and estradiol and their nonsulfated and sulfated metabolites in serum, myometrium, and vagina of postmenopausal women following treatment for 21 days with tibolone, estradiol, or estradiol plus medroxyprogestrone acetate.
    Reproductive sciences (Thousand Oaks, Calif.), 2007, Volume: 14, Issue:2

    Topics: Aged; Estradiol; Estrone; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Myometrium; Norpregnenes; Postmenopause; Selective Estrogen Receptor Modulators; Tissue Distribution; Uterine Prolapse; Vagina

2007

Other Studies

33 other study(ies) available for estrone and medroxyprogesterone acetate

ArticleYear
An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin.
    Journal of medicinal chemistry, 2008, Apr-10, Volume: 51, Issue:7

    Topics: Binding Sites; Binding, Competitive; Computer Simulation; Databases as Topic; Humans; Ligands; Linear Models; Models, Molecular; Predictive Value of Tests; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Sex Hormone-Binding Globulin; Steroids

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Long-term treatment with transcutaneous estradiol and oral medroxyprogesterone acetate.
    Acta obstetricia et gynecologica Scandinavica, 1992, Volume: 71, Issue:8

    Topics: Administration, Cutaneous; Administration, Oral; Climacteric; Delayed-Action Preparations; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Follicle Stimulating Hormone; Humans; Lipids; Luteinizing Hormone; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Sex Hormone-Binding Globulin

1992
Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate.
    Obstetrics and gynecology, 1990, Volume: 75, Issue:4

    Topics: Adult; Drug Therapy, Combination; Endometriosis; Estradiol; Estrone; Female; Flushing; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Pain; Pelvic Neoplasms

1990
The effect of medroxyprogesterone acetate on aromatase and DNA polymerase alpha activities in breast tumours.
    Journal of steroid biochemistry, 1989, Volume: 34, Issue:1-6

    Topics: Aged; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Cell Division; DNA Polymerase II; Estrone; Female; Humans; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Tumor Cells, Cultured

1989
The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients.
    British journal of cancer, 1987, Volume: 55, Issue:3

    Topics: Androstenedione; Antineoplastic Agents; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Sex Hormone-Binding Globulin; Testosterone

1987
The effects of estrogen and progestin on endogenous opioid activity in oophorectomized women.
    The Journal of clinical endocrinology and metabolism, 1985, Volume: 60, Issue:1

    Topics: Adult; beta-Endorphin; Castration; Endorphins; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Follicular Phase; Humans; Luteal Phase; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Naloxone; Progestins; Prolactin

1985
Progestins increase endogenous opioid peptide activity in postmenopausal women.
    The Journal of clinical endocrinology and metabolism, 1985, Volume: 60, Issue:1

    Topics: Aged; Endorphins; Estradiol; Estrone; Female; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Naloxone; Progestins; Prolactin

1985
Inhibition of steroid sulfatase activity by danazol.
    Acta obstetricia et gynecologica Scandinavica. Supplement, 1984, Volume: 123

    Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma; Culture Techniques; Danazol; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estrogen Antagonists; Estrone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnadienes; Tamoxifen

1984
Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women.
    Obstetrics and gynecology, 1984, Volume: 63, Issue:1

    Topics: Adult; Calcium; Creatinine; Delayed-Action Preparations; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Humans; Hydroxyproline; Immunosuppressive Agents; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Random Allocation

1984
Blastocyst implantation in ovariectomized, adrenalectomized hamsters treated with inhibitors of steroidogenesis during the pre-implantation period.
    Steroids, 1980, Volume: 36, Issue:1

    Topics: Adrenalectomy; Aminoglutethimide; Animals; Blastocyst; Castration; Cricetinae; Cyanoketone; Embryo Implantation; Embryonic Development; Estradiol; Estrone; Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Mesocricetus; Ovary; Pregnancy; Progesterone; Prostaglandins; Uterus

1980
Stimulation of arylsulfotransferase activity by progestins in human endometrium in vitro.
    The Journal of clinical endocrinology and metabolism, 1981, Volume: 53, Issue:2

    Topics: Arylsulfotransferase; Cells, Cultured; Endometrium; Estradiol; Estradiol Dehydrogenases; Estrone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Phenols; Phosphoadenosine Phosphosulfate; Progesterone; Sulfurtransferases

1981
[Assessment of serum estrogen levels by RIA with HPLC during hormone replacement therapy].
    Nihon Sanka Fujinka Gakkai zasshi, 1995, Volume: 47, Issue:7

    Topics: Adult; Chromatography, High Pressure Liquid; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Postmenopause; Radioimmunoassay; Uterine Hemorrhage

1995
Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat.
    Breast cancer research and treatment, 1995, Volume: 34, Issue:2

    Topics: 17-Hydroxysteroid Dehydrogenases; 9,10-Dimethyl-1,2-benzanthracene; Adrenal Glands; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Drug Synergism; Estradiol; Estrenes; Estrogen Antagonists; Estrone; Female; Follicle Stimulating Hormone; Luteinizing Hormone; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Organ Size; Ovariectomy; Rats; Rats, Sprague-Dawley; Uterus

1995
Blood flow variations in internal carotid and middle cerebral arteries induced by postmenopausal hormone replacement therapy.
    American journal of obstetrics and gynecology, 1993, Volume: 169, Issue:5

    Topics: Administration, Cutaneous; Carotid Artery, Internal; Cerebral Arteries; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Pulsatile Flow; Regional Blood Flow; Ultrasonography

1993
Androgen receptor-mediated stimulation of 17 beta-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells.
    Endocrinology, 1993, Volume: 132, Issue:1

    Topics: 17-Hydroxysteroid Dehydrogenases; Breast Neoplasms; Dexamethasone; Dihydrotestosterone; Estradiol; Estrone; Flutamide; Humans; Kinetics; Medroxyprogesterone Acetate; Receptors, Androgen; Tumor Cells, Cultured

1993
Potent inhibitory effects of steroids in an in vitro model of angiogenesis.
    The Journal of endocrinology, 1996, Volume: 150, Issue:3

    Topics: 17-alpha-Hydroxyprogesterone; Androstenedione; Animals; Aorta; Cortodoxone; Culture Techniques; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Hydrocortisone; Medroxyprogesterone Acetate; Models, Biological; Neovascularization, Physiologic; Progesterone; Rats; Rats, Wistar

1996
The effect of hormone replacement therapy on vitamin E status in postmenopausal women.
    Maturitas, 1997, Volume: 26, Issue:2

    Topics: Antioxidants; Arteriosclerosis; Cell Membrane; Chromatography, High Pressure Liquid; Contraceptives, Oral; Erythrocytes; Estradiol Congeners; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Follow-Up Studies; Humans; Incidence; Lipids; Lipoproteins, LDL; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Vitamin E

1997
Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats.
    International journal of cancer, 1997, Nov-14, Volume: 73, Issue:4

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Adrenal Glands; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Benzopyrans; Carcinogens; Cell Division; Drug Screening Assays, Antitumor; Estrogen Antagonists; Estrone; Female; Luteinizing Hormone; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Organ Size; Propionates; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Progesterone; Uterus; Vagina

1997
In vitro lipid peroxidation of LDL from postmenopausal cynomolgus macaques treated with female hormones.
    Journal of lipid research, 1999, Volume: 40, Issue:2

    Topics: Alkenes; alpha-Tocopherol; Amidines; Animals; Cholesterol, HDL; Copper; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; gamma-Tocopherol; Lipid Peroxidation; Lipoproteins, LDL; Macaca fascicularis; Medroxyprogesterone Acetate; Molecular Weight; Multivariate Analysis; Tamoxifen

1999
Progestin regulation of 11beta-hydroxysteroid dehydrogenase expression in T-47D human breast cancer cells.
    The Journal of steroid biochemistry and molecular biology, 2000, Volume: 72, Issue:5

    Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Breast Neoplasms; Carcinoma; Corticosterone; Dose-Response Relationship, Drug; Estradiol; Estrone; Female; Gene Expression Regulation, Enzymologic; Humans; Hydroxysteroid Dehydrogenases; Medroxyprogesterone Acetate; Mifepristone; NAD; Progesterone Congeners; Progestins; RNA, Messenger; Tumor Cells, Cultured

2000
Effect of estrogen and progesterone on gene expression of growth regulatory molecules and proto-oncogene in vascular smooth muscle cells.
    Endocrine journal, 2000, Volume: 47, Issue:3

    Topics: Arteriosclerosis; Blotting, Southern; Cells, Cultured; Drug Interactions; Estrone; Gene Expression Regulation, Developmental; Humans; Interleukin-1; Interleukin-6; Medroxyprogesterone Acetate; Muscle Development; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Proto-Oncogene Mas; Proto-Oncogene Proteins c-myc; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2000
Ultrastructure of endometrium of postmenopausal patients on two modes of hormonal therapy: estrone sulfate with or without MPA.
    Contraceptive delivery systems, 1983, Volume: 4, Issue:1

    Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Endocrine System; Endometrium; Estrogens; Estrone; Family Planning Services; Genitalia; Genitalia, Female; Histology; Hormones; Medroxyprogesterone Acetate; Menopause; Physiology; Reproduction; Reproductive Control Agents; Therapeutics; Urogenital System; Uterus

1983
Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance.
    Circulation, 2003, May-27, Volume: 107, Issue:20

    Topics: Arteries; Delayed-Action Preparations; Endothelium, Vascular; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Humans; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Menstrual Cycle; Receptors, Androgen; Substrate Specificity; Time

2003
Influence of postmenopausal hormone replacement therapy on an estrogen metabolite biomarker of risk for breast cancer.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2003, Volume: 35, Issue:6

    Topics: Biomarkers, Tumor; Breast Neoplasms; Cross-Sectional Studies; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hydroxyestrones; Medroxyprogesterone Acetate; Postmenopause; Risk Factors

2003
5-benzylidene-1,2-dihydrochromeno[3,4-f]quinolines as selective progesterone receptor modulators.
    Journal of medicinal chemistry, 2003, Sep-11, Volume: 46, Issue:19

    Topics: Androgen Receptor Antagonists; Animals; Benzylidene Compounds; Binding, Competitive; Breast Neoplasms; Cell Division; Cells, Cultured; Chlorocebus aethiops; Epithelial Cells; Estrone; Female; Humans; Mammary Glands, Animal; Medroxyprogesterone Acetate; Progesterone; Progesterone Congeners; Quinolines; Rats; Receptors, Androgen; Receptors, Glucocorticoid; Receptors, Progesterone; Structure-Activity Relationship; Uterus; Vagina

2003
DELAYED IMPLANTATION IN INTACT RATS TREATED WITH MEDROXYPROGESTERONE ACETATE.
    Journal of reproduction and fertility, 1964, Volume: 7

    Topics: Animals; Embryo Implantation, Delayed; Estrone; Female; Fertilization; Medroxyprogesterone; Medroxyprogesterone Acetate; Pharmacology; Pregnancy; Pregnancy, Animal; Rats; Research

1964
Progestins affect mechanism of estrogen-induced C-reactive protein stimulation.
    The American journal of medicine, 2006, Volume: 119, Issue:2

    Topics: C-Reactive Protein; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Humans; Interleukin-6; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progestins; Randomized Controlled Trials as Topic; Sex Hormone-Binding Globulin

2006
Differences in brain volumes among males and female hormone-therapy users and nonusers.
    Psychiatry research, 2006, Oct-30, Volume: 147, Issue:2-3

    Topics: Aged; Brain; Cognition; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Health Status; Humans; Magnetic Resonance Imaging; Male; Medroxyprogesterone Acetate; Neuropsychological Tests

2006
Depot-medroxyprogesterone acetate and endothelial function before and after acute oral, vaginal, and transdermal estradiol treatment.
    Hypertension (Dallas, Tex. : 1979), 2011, Volume: 57, Issue:4

    Topics: Adolescent; Adult; Analysis of Variance; Blood Flow Velocity; Blood Pressure; Brachial Artery; Contraceptive Agents, Female; Drug Administration Routes; Endothelin-1; Endothelium, Vascular; Estradiol; Estrogens; Estrone; Female; Heart Rate; Humans; Immunoassay; Linear Models; Medroxyprogesterone Acetate; Ultrasonography; Vasodilation

2011